4//SEC Filing
Gilde Healthcare Holding B.V. 4
Accession 0000899243-21-017131
CIK 0001719395other
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 7:31 PM ET
Size
30.8 KB
Accession
0000899243-21-017131
Insider Transaction Report
Form 4
Eargo, Inc.EAR
Gilde Healthcare Holding B.V.
10% Owner
Transactions
- Sale
Common Stock
2021-04-26$50.25/sh−14,910$749,228→ 3,653,781 total(indirect: See footnote) - Sale
Common Stock
2021-04-26$54.16/sh−69,404$3,758,921→ 3,441,076 total(indirect: See footnote) - Sale
Common Stock
2021-04-23$50.11/sh−72,707$3,643,348→ 3,686,075 total(indirect: See footnote) - Sale
Common Stock
2021-04-23$50.75/sh−17,384$882,238→ 3,668,691 total(indirect: See footnote) - Sale
Common Stock
2021-04-26$52.29/sh−19,032$995,183→ 3,618,484 total(indirect: See footnote) - Sale
Common Stock
2021-04-27$56.21/sh−911$51,207→ 3,307,450 total(indirect: See footnote) - Sale
Common Stock
2021-04-27$55.53/sh−35,377$1,964,485→ 3,308,361 total(indirect: See footnote) - Sale
Common Stock
2021-04-23$49.28/sh−61,035$3,007,805→ 3,758,782 total(indirect: See footnote) - Sale
Common Stock
2021-04-26$53.36/sh−108,004$5,763,093→ 3,510,480 total(indirect: See footnote) - Sale
Common Stock
2021-04-27$54.66/sh−68,525$3,745,576→ 3,343,738 total(indirect: See footnote) - Sale
Common Stock
2021-04-26$51.30/sh−16,265$834,395→ 3,637,516 total(indirect: See footnote) - Sale
Common Stock
2021-04-27$53.70/sh−28,813$1,547,258→ 3,412,263 total(indirect: See footnote)
Footnotes (13)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $48.56 to $49.54, inclusive. The Reporting Persons undertake to provide to Eargo, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $53.07 to $54.05, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $54.07 to $55.07, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F12]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $55.07 to $56.04, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F13]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $56.13 to $56.28, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F2]These shares are held directly by Cooperatieve Gilde Healthcare V U.A. ("Gilde"). Gilde is managed by Gilde Healthcare V Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $49.55 to $50.54, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $50.55 to $51.09, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $49.82 to $50.80, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $50.82 to $51.79, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $51.84 to $52.83, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $52.85 to $53.84, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $53.85 to $54.52, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Documents
Issuer
Eargo, Inc.
CIK 0001719395
Entity typeother
IncorporatedNetherlands
Related Parties
1- filerCIK 0001420106
Filing Metadata
- Form type
- 4
- Filed
- Apr 26, 8:00 PM ET
- Accepted
- Apr 27, 7:31 PM ET
- Size
- 30.8 KB